Topic:

Emerging Markets

Latest Headlines

Latest Headlines

Mega Lifesciences to expand in Indonesia on partnership with Sydna Farma

Thailand-based pharma manufacturer Mega Lifesciences is partnering with Sydna Farma of Singapore as part of its efforts to expand into Indonesia.

Researchers ready consumer STD-detecting, connected ring for Indiegogo in early 2016

An international entrepreneurial trio has developed a hand-worn ring that detects syphilis, gonorrhea, chlamydia and trichomoniasis--wirelessly transmitting the results to a smartphone or tablet in under one minute. Known as Hoope, the device has a retractable needle and an anesthetic system based on electrical pulses; it is slated to debut on crowdfunding site Indiegogo in January.

Big Pharma, rejoice: China aims to speed up approvals for new meds

Relations between China and foreign drugmakers have been thawing for a while, with the country announcing late last year that it would toss out restrictive price caps and streamline drug approvals for companies. Now, China is throwing multinational drugmakers another bone as it plans to reduce lengthy approval times for innovative drugs.  

Another Indian CRO draws the ire of Western regulators

An Indian CRO that counts Johnson & Johnson, Novartis and Sanofi among its clients is under fire from the FDA for repeated quality control issues, the latest ding to the country's reputation as a go-to destination for outsourced drug development.

How slow can Big Pharma go in emerging markets?

Industry watchers have pointed to a slowdown in pharma's emerging markets growth as a worrying sign for companies that have been heavily targeting developing nations while the U.S. and European markets stagnate. But just how slow has the growth become?

Sisu to put emergency blood recycling device through trials later this year

Sisu Global Health, which specializes in developing medical devices tailored to meet a specific need in a community, will launch a clinical study later this year for a device that can recycle a patient's blood lost through traumatic internal bleeding.

Big Pharma feels the pain in China, with AZ delivering the only 10%-plus sales hike

Not so long ago, China was such a promising pharma market that drugmakers recruited hundreds of new sales reps to race after a share. But growth is slowing there now, and drug companies are feeling it.

FDA warning letter smacks Indian lab for repeated shortcomings

The FDA has issued warning letters blasting any number of Indian API and drugmakers for not carefully testing drugs or sometimes fabricating test results of batches of their products that they shipped to the U.S. Now the agency has sent a warning letter to an Indian contractor some companies rely on for product testing and analysis, noting repeat violations of GMP standards.

GSK rehires whistleblower linked to China bribery scandal

GlaxoSmithKline is still dealing with the aftermath of its China bribery scandal. As the dust settles, the company is rehiring a former senior Chinese employee once suspected of blowing the whistle on GSK in the country.

GSK envisions 'thoughtful, staged rollout' for Mosquirix

GlaxoSmithKline's malaria jab got the green light from the EMA on Friday and the British pharma is making plans for a gradual rollout of the vaccine.